FDA-approved carbon copies of brand-name drugs with expired patents—over the last 30 years, these generic drugs have saved trillions of dollars for hundreds of millions of people.
3 hours ago
0
2
Federal law requires every prescription drug to include a document describing dosing guidelines, contraindications, results from clinical trials and safety considerations. But a spate of recent court decisions has problematically ...
Feb 16, 2026
0
9
The U.K.'s supply of essential medicines is in a fragile state, with a "vicious cycle" where rising costs and supply chain issues are making it harder for patients to get the treatments they need, according to a new House ...
Feb 12, 2026
0
9
The U.S. Food and Drug Administration has appointed George Francis Tidmarsh, M.D., Ph.D., as director of the Center for Drug Evaluation and Research (CDER).
Jul 23, 2025
0
7
Generic drugs manufactured in India are linked to significantly more "severe adverse events" for patients who use them than equivalent drugs produced in the United States, a new study finds.
Feb 19, 2025
0
27
A new study from the University of Iowa finds that many drug prices actually drop after pharmaceutical company mergers, challenging the belief that mergers are the primary cause of rising drug prices in the United States. ...
Jan 13, 2025
0
22
Reports of drug-related supply-chain issues were 40% less likely to result in drug shortages in Canada versus the United States, according to a study from University of Pittsburgh researchers and published in JAMA.
Oct 31, 2024
0
20
Prescription drug prices in the U.S. are significantly higher than in other nations, with prices in the U.S. averaging 2.78 times those seen in 33 other nations, according to a new RAND report.
Feb 1, 2024
0
47
Medicare is the single largest provider of health insurance in the United States, serving 63.8 million senior citizens as of 2022. Three-quarters of these recipients are enrolled in optional Medicare Part D plans, which provide ...
Dec 5, 2023
0
49
Swiss generic drugs group Sandoz began trading as an independent company in Zurich on Wednesday, in a stock market debut following a spin-off by parent company Novartis as it pivots toward new drug development.
Oct 4, 2023
0
70
